NCT04091243View on ClinicalTrials.gov

Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

October 15, 2023

Study Completion Date

November 15, 2023

Conditions
Glucocorticoid-induced Osteoporosis
Interventions
DRUG

Romosozumab

Experimental drug for the treatment of glucocorticoid induced osteoporosis

Trial Locations (1)

Unknown

Tuen Mun Hospital, Hong Kong

All Listed Sponsors
lead

Tuen Mun Hospital

OTHER_GOV

NCT04091243 - Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users | Biotech Hunter | Biotech Hunter